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INTRODUCTION
Otitis media with effusion (OME) is associated with bacterial in-
fections of the upper respiratory tract and dysfunction of the 
Eustachian tubes. Several other factors may also be involved in 
the development of OME, including the host immune system, 
environmental factors, family history, allergies, adenoid hypertro-
phy, chronic sinusitis, cleft palate, tumors, or even sharp changes 
in atmospheric pressure. Recently, it was reported that in many 
cases of OME, bacteria or viruses are found in middle ear effu-
sion. Since pediatric patients with OME often have previous his-
tories of acute otitis media (AOM); OME is often regarded as 
the same disease as AOM (1). Therefore, understanding the in-
fections involved in AOM and following the immune response in 
the middle ear cavity are critical to determining the pathophysi-
ological mechanism of OME.
  The human body is constantly threatened by pathogens such 
as viruses, bacteria, fungi and parasites. In cases of infection the 
innate or adaptive immune system, or a cooperative interaction 
of both, release various immunological mediators. The innate 
immune system is considered the first line of defense during the 
host response to pathogens, and the body discriminates and in-
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fectious non-self from noninfectious self based on the recogni-
tion of general patterns (2, 3). Pattern recognition receptors (PRRs) 
in humans, including Toll-like receptors (TLRs) and cytoplasmic 
nucleotide-binding oligomerization domain (NOD)-like recep-
tors (NLRs), recognize conserved molecular signatures known 
as pathogen-associated molecular patterns (PAMPs) to sense the 
presence of microbial infections (4). 
  Recent studies on PRR expressions in pediatric patients with 
OME have reported that the decreased expression of PRRs may 
be associated with increased susceptibility to OME (5, 6). Even 
though no mutations had been found in TLR-2 and -4, which 
were expressed in all isolated samples of middle ear fluids, lev-
els of TLR-9 and NOD-1 mRNAs were significantly lower in in-
dividuals with recurrent OME (6). Based on this, we hypothe-
sized that there may be a difference in expression level of PRRs 
dependent on the clinical states of OME. Thus, in the present 
study we focused on the innate immune response in OME pa-
tients according to the characteristics of effusion fluids, presence 
of bacteria in exudates, and the frequency of ventilation tube 
insertion. Specifically, in the innate immune response in OME, 
we addressed the expressions of TLR-2, -4, -5, -9, NOD-1, and 
-2, which may play important roles in bacterial infection. 
MATERIALS AND METHODS
The study sample consisted of 46 pediatric patients who visited 
the Department of Otorhinolaryngology at our hospital from 
January 2008 to April 2010 and underwent ventilation tube in-
sertion for chronic OME. OME was diagnosed by the presence 
of an amber-colored tympanic membrane on otoscopic exami-
nation and by the presence of B- or C-type tympanograms as 
shown by impedance audiometry. Surgery was performed on 
chronic OME patients who did not show improvement after 2 
weeks of antibiotic treatment and in patients who, after a 2–3 
month follow-up, showed progressive retraction of the eardrum 
or progression of hearing loss as shown by an increase in pure 
tone threshold.
  We received prior permission with written informed consent 
from the patients’ parents or guardians for using patient sam-
ples, and the purpose of the experiment was also explained to 
them. Children who were suspected of having acute otitis me-
dia, head and neck anomalies, systemic diseases, or congenital 
or acquired immunodeficiencies were excluded.
  A tympanostomy tube was inserted after a radial shaped inci-
sion was made in the anterior inferior quadrant of the tympanic 
membrane. Prior to surgery, the external auditory canal was 
washed with potadine solution, and middle ear effusion fluid 
(MEEF) was collected using a collector (Xomed Treace Products, 
Jacksonville, FL, USA) by aseptic procedures, taking care to 
avoid bleeding. Each effusion fluid sample was collected using 
sterilized cotton swabs, added to Stuart transport medium, and 
used to inoculate blood agar medium and thioglycollate liquid 
medium. All cultures were incubated for at least 24 hours at 35°C, 
and the resultant bacteria were identified by Gram-staining and 
biochemical analyses. 
  Total RNA was extracted from effusion using the RNA-Bee 
solution kit (Tel-Test, Friendswood, TX, USA) following the 
manufacturer’s protocol. First-strand cDNA synthesis was per-
formed by reverse transcription in a total volume of 20 μL reac-
tion mixture containing 1 μg of RNA, 1x reaction buffer, 1 mM 
dNTP, 5 μM random primers, 20 units RNase inhibitor, and 20 
units AMV reverse transcriptase (Promega, Madison, WI, USA). 
The reaction mixture was incubated at 42°C for 1 hour, termi-
nated by heating at 95°C for 5 minutes. TLR-2, -4, -5, -9, NOD-
1 and -2 primers are shown in Table 1. 
  Real-time polymerase chain reaction (PCR) was performed 
using a Chromo4 Detector real-time system (Bio-Rad, Hercules, 
CA, USA) with the SsoFast EvaGreen supermix (Bio-Rad). PCR 
was performed with 2 μL of cDNA in a 20 μL reaction mixture 
of 10 μL SsoFast EvaGreen supermix, 2 μL primers and 6 μL 
PCR grade water. The reaction parameters were as follows: de-
naturation at 95°C for 30 seconds followed by 45 cycles at 95°C 
for 5 seconds, 55°C to 64°C for 12 seconds. The crossing point 
of TLR-2, -4, -5, -9, NOD-1, or -2 with β-actin was applied to the 
formula, 2
-(target gene- β actin) and the relative amounts were quantitat-
ed. Difference of PRRs expression level by presence of bacteria, 
ventilation tube insertion rate, and effusion fluid character was 
assessed.
  Between group differences in PRRs expression, bacterial cul-
ture results, and frequency of ventilating tube insertion were 
compared using the Mann-Whitney U-test. The relationship be-
tween the expression level of PRRs and characteristics of effu-
sion fluid was analyzed by the Kruskal Wallis test. All statistical 
calculations were performed using SPSS ver. 11.5 (SPSS Inc., 
Table 1. Primers for real-time RT-PCR 
Name Sequences
Annealing 
temperature
Product 
size
TLR 2 F:5’-GCCAAAGTCTTGATTGATTGG-3’ 64 347
R:5’-TTGAAGTTCTCCAGCTCCTG-3’
TLR 4 F:5’-TGGATACGTTTCCTTATAAG-3’ 55 507
R:5’-GAAATGGAGGCACCCCTTC-3’
TLR 5 F:5’-CTAGCTCCTAATCCTGATG-3’ 55 438
R:5’-CCATGTGAAGTCTTTGCTGC-3’
TLR 9 F:5’-CCCTCAACTTCACCTTGGATCT-3’ 64 428
R:5’-CCACATATGGCCCAGTGCA-3’
NOD 1 F:5’-TGATGCTGTTTCTGCCTCTC-3’ 56 374
R:5’-AATTTGACCCCTGCGTCTAG-3’
NOD 2 F:5’-AGCCATTGTCAGGAGGCTC-3’ 56 319
R:5’-CGTCTCTGCTCCATCATAGG-3
β-actin F;5’-CTTCTACAATGAGCTGCGTG-3’ 55 305
R;5’-TCATGAGGTAGTCAGTCAGG-3’
RT-PCR: real time-polymerase chain reaction; TLR: Toll-like receptor; NOD: 
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Chicago, IL, USA), and P-values lower than 0.05 were consid-
ered statistically significant. 
RESULTS
The study sample consisted of 46 children with OME, 35 boys 
and 11 girls with a mean age 4.7 (±2.1) years. Effusion fluids 
from all 46 of these patients were collected during the insertion 
of tympanostomy tubes. TLR-2, -4, -5, -9, NOD-1, and -2 were 
expressed in all middle ear exudates; TLR-9 showed the highest 
expression level, followed by TLR-2, TLR-4, TLR-5, NOD-2, and 
NOD-1. The characteristics of effusion fluid presented 17 mu-
coid cases, 16 serous cases, 10 mucopurulent cases and 3 puru-
lent cases. There were no significant differences among mRNA 
levels of TLR-2, -4, -5, -9, NOD-1, and -2 regardless of their ef-
fusion characteristics (P>0.05) (Table 2). 
  Of the 46 samples examined, 31 (67.4%) were negative for 
growth of bacteria, whereas the remaining 15 (32.6%) showed 
bacterial growth from the effusion fluid. Bacteria were cultured 
and identified; the bacterial species identified were coagulase-
negative Staphylococcus (CNS), methicillin-resistant Staphylo-
coccus aureus (MRSA), Streptococcus pneumonia, Micrococcus 
spp., Pseudomonas aeruginosa, methicillin-sensitive Staphylo-
coccus aureus, Streptococcus viridians, and Acinotobacter iwof-
fi (Table 3). 
  We observed expressions of TLR-2, -4, -5, -9, NOD-1, and -2 
mRNAs in all effusion samples. We observed no differences be-
tween the presence of bacteria in exudates and the expression 
levels of TLR-9, NOD-1, and NOD-2 mRNA (P>0.05) (Table 4). 
In addition, expression levels of PRRs mRNA were not associat-
ed with the frequency of ventilating tube insertion (P>0.05) 
(Table 5). Similarly, there were no differences between frequen-
cies of ventilation tube insertion and expression levels of PRRs, 
regardless of the presence of bacteria in middle ear fluid (P>0.05) 
(Table 6). 
DISCUSSION
PRRs are a class of proteins that respond to PAMPs while the 
innate immune system reacts. These receptors are expressed in 
different cellular compartments such as on the cell surface, and 
in the endosomes, lysosomes or cytoplasm; they have been 
shown to differ in intracellular localization, recognition of differ-
ent pathogenic motifs, and cell signaling (7). For example, TLR-
Table 2. Expression of PRRs according to characteristics of exudates (relative expression ∆Ct)
Mucoid Serous Mucopurulent Purulent P-value
TLR2 0.061±0.051 0.168±0.218 0.151±0.160 0.197±0.151 0.248
TLR4 0.034±0.024 0.083±0.072 0.091±0.061 0.049±0.018 0.064
TLR5 0.034±0.038 0.055±0.051 0.060±0.052 0.051±0.013 0.551
TLR9 0.154±0.149 0.298±0.268 0.099±0.105 0.183±0.107 0.140
NOD1 0.003±0.002 0.008±0.016 0.005±0.006 0.004±0.003 0.646
NOD2 0.005±0.003 0.039±0.070 0.017±0.013 0.013±0.001 0.297
PRRs: pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleotide-binding oligomerization domain; ∆Ct: threshold cycle.
Table 3. Culture results from middle ear effusion fluid
Bacteriology No. (%)
No growth 31 (67.4)
Coagulase-negative staphylococci 3 (6.5)
Methicillin-resistant staphylococcus aureus 2 (4.3)
Streptococcus pneumoniae 2 (4.3)
Micorococcus spp. 2 (4.3)
Pseudomonas aeruginosa 2 (4.3)
Staphylococcus aureus 2 (4.3)
Streptococcus viridans 1 (2.1)
Acinotobacter iwoffi 1 (2.1)
Total 46
Table 4. Expression of PRRs according to bacterial culture results in 
effusion fluid (relative expression ∆Ct)
Non-bacterial  
detection 
Bacterial  
detection  
P-value
TLR2 0.123±0.166 0.113±0.106 0.822
TLR4 0.069±0.063 0.058±0.066 0.565
TLR5 0.043±0.048 0.059±0.067 0.876
TLR9 0.182±0.210 0.241±0.267 0.691
NOD1 0.006±0.011 0.004±0.003 0.139
NOD2 0.022±0.047 0.007±0.005 0.089
PRRs: pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleo-
tide-binding oligomerization domain; ∆Ct: threshold cycle.
Table 5. Expression of PRRs according to the frequency of ventilat-
ing tube insertion (relative expression ∆Ct)
Once   Twice or more  P-value
TLR2 0.115±0.155 0.136±0.090 0.525
TLR4 0.066±0.066 0.063±0.043 0.449
TLR5 0.044±0.051 0.072±0.061 0.128
TLR9 0.175±0.217 0.183±0.196 0.437
NOD1 0.006±0.012 0.004±0.006 0.868
NOD2 0.021±0.049 0.013±0.008 0.811
PRRs: pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleo-
tide-binding oligomerization domain; ∆Ct: threshold cycle.166    Clinical and Experimental Otorhinolaryngology   Vol. 4, No. 4: 163-167 , December 2011
2, -4, and -5 are located on the cell surface, TLR-9 is present on 
endosomal and lysosomal membranes, and NOD-1 and -2 re-
ceptors are located in the cytoplasm. TLR-2 and -4 have been 
reported to recognize pathogenic bacteria, whereas TLR-2 is the 
receptor for the cell wall components of Gram-positive bacteria 
including peptidoglycans, lipoteichoic acid and lipoproteins, and 
TLR-4 binds to the toxic pneumolysin ligand produced by Gram-
positive bacteria, as well as binding to lipopolysaccharide (LPS), 
the major component of Gram-negative bacterial cell walls (8-
10). Both NOD-1 and -2 have cytoplasmic caspase-recruiting ef-
fector domains and recognize peptidoglycan fragments. NOD-1 
recognizes Gram-negative bacteria, whereas NOD-2 recognizes 
both Gram-positive and Gram-negative bacteria (11). Inflamma-
tory diseases caused by the abnormal immune control of noso-
comical infections may be due to some problem with expression 
levels of PRRs. Despite the fact that PRRs may play a crucial 
role in the innate immune response, little is known about how 
and when the innate immune system reacts with pathogens in-
vading the middle ear cavity in pediatric patients with OME. 
Thus, we not only assayed the expressions and relationships 
among PRRs, but we also aimed to discern whether there were 
differential expression levels of PRRs according to bacterial in-
fection.
  TLRs serve a sentinel role in early detection for invading patho-
gens so that the host can activate local inflammation through the 
expression of innate immune mediators such as the complement 
cascade. When there is a mutation in TLRs, not only otitis media, 
but periodontitis and osteomyelitis can also occur due to the re-
duced ability for bacterial cell wall recognition and an increased 
susceptibility to bacterial infection (12-16). TLR-2 and -4 were 
reported to be involved in defense mechanism of the middle ear 
cavity and in the bacterial alleviation or clearance of OME. Ge-
netic mutation of TLR-2 or -4 was also reported to increase the 
susceptibility for bacterial infection in OME (6, 17). In our study, 
we confirmed that TLR-2 and -4 were expressed in exudates of 
OME. TLR-5 and -9 that are related to the response to bacterial 
infection were also expressed in the middle ear effusion. These 
results imply that the difference of PRRs expression levels may 
be closely associated with the development of OME.
  The role of cytoplasmic receptors becomes critical when patho-
gens that have the ability to escape from TLR recognition enter 
the body (18). The expression levels of many cytoplasmic recep-
tors stay low under normal conditions, but when pathogens in-
vade and pro-inflammatory cytokines are manifested, their ex-
pressions are highly induced. Our results showed simultaneous 
expression of the cytoplasmic receptors NOD-1 or NOD-2 along 
with the TLRs in all cases regardless of bacterial presence or 
species. This suggests that PRRs function cooperatively rather 
than individually in OME. 
  Previous studies on the immunological status of the host in 
otitis media have asserted that the independent local immunity 
of the middle ear cavity is one of the main causes of OME (19, 
20). The close relationship between bacterial infection and the 
innate immune response of OME can be deduced because bac-
teria were detected in exudates of the middle ear cavity, and 
children with a higher prevalence for upper airway infection 
were more likely to develop OME. These findings suggest that 
bacterial infection probably plays an important role in the de-
velopment of OME (21). 
  Some have presented an association between the level of an-
tibody in the middle ear effusions and bacterial infection, and 
suggested that the higher concentrations of immunoglobulin in 
middle ear effusions from patients with acute otitis media are 
associated with lower detection rates of bacteria. Other research 
has showed that the serum levels of immunoglobulin from chil-
dren with OME may be closely related to bacterial infection (20). 
These studies led to the examination of the relationship between 
bacterial infection and the acquired immune response in otitis 
media (1, 20). However, there was no correlation between effu-
sion Ig concentration and the presence of bacteria in OME. In 
order to determine the relationship between bacterial infection 
and innate immunity, the expression levels of PRRs were com-
pared between subjects who were detected of bacteria and those 
who were not detected of bacteria in exudates, and we found no 
relationship between bacterial infection and PRRs. However, it 
is still important to note the possible involvement of PRRs in 
immune response to otitis media, since PRRs were expressed in 
all exudate samples from otitis media regardless of bacterial de-
tection. 
  There are some limitations in this study. First, the study did 
not include children with early stage OME. Second, antibiotics 
had been used for 2 weeks to treat early stage of symptoms in 
Table 6. Expression of PRRs according to culture results and the frequency of ventilating tube insertion (relative expression ∆Ct)
Culture (+) Culture (-)
P-value
Once Twice or more Once Twice or more
TLR2 0.113±0.162 0.107±0.081 0.122±0.145 0.196±0.093 0.821
TLR4 0.070±0.074 0.056±0.044 0.056±0.043 0.077±0.047 0.898
TLR5 0.046±0.055 0.056±0.069 0.041±0.045 0.099±0.042 0.300
TLR9 0.133±0.167 0.180±0.192 0.217±0.267 0.195±0.198 0.476
NOD1 0.008±0.015 0.004±0.005 0.004±0.005 0.008±0.006 0.883
NOD2 0.017±0.049 0.007±0.008 0.018±0.023 0.036±0.038 0.811
PRRs: pattern recognition receptors; TLR: Toll-like receptor; NOD: nucleotide-binding oligomerization domain; ∆Ct: threshold cycle.Lee SY et al.: TLR and NOD in Otitis Media with Effusion    167
all patients. Third, 67.4% showed negative growth despite bacte-
rial infection possibly due to the use of various antibiotics prior 
to myringotomy and insertion of ventilation tubes, creating a 
bacteriostatic condition and delaying the proliferation and growth 
of pathogens. Fourth, only the middle ear effusion was tested 
for bacteria and not the mucous membrane of the middle ear. 
The exudate contains only a few partially exfoliated mucosal 
epithelial cells and inflammatory cells; this would not fully re-
flect the immune cells in the middle ear mucosa during infec-
tion, but we obviously could not collect the middle ear mucosa 
of patients due to ethical issues. Finally, as the exudates used in 
this study were collected during surgery 2-3 months after the 
occurrence of the initial onset of otitis media, our study may not 
fully reflect the innate immune response in the middle ear cavi-
ty. PRRs were expressed in all exudates samples of otitis media 
regardless of bacterial detection. Our study showed similar PRRs 
expression values between the group that received reoperation 
from the recurrence of OME and the group with only one oper-
ation. This suggests that innate immunity may be involved in the 
middle ear cavity irrespective of the recurrence of OME. 
  This study confirmed that all exudates of OME patients showed 
some level of PRR expression related to innate immune response 
regardless of characteristics of effusion fluid, presence of bacte-
ria in exudates, or frequency of ventilation tube insertion. 
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